SCHEMBL13250997

SCHEMBL13250997

COc1ccc(-c2cc(-c3cc4ccccc4c4ccccc34)c3ccc4c(-c5ccc(OC)cc5)cc(-c5cc6ccccc6c6ccccc56)c5ccc2c3c45)cc1

nearest known ligand 0.51

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ACACA Q13085 1/20 0.51
▸ GPR84 Q9NQS5 1/20 0.50
▸ ALOX5 P09917 1/20 0.47
▸ KDM4E B2RXH2 4/20 0.47
▸ MAPT P10636 3/20 0.47
▸ ALDH1A1 P00352 3/20 0.47
▸ HPGD P15428 2/20 0.47
▸ TDP1 Q9NUW8 2/20 0.47
▸ SMN1; SMN2 Q16637 1/20 0.47
▸ ABCB1 P08183 2/20 0.46
▸ ABL1 P00519 1/20 0.46
▸ BCR P11274 1/20 0.46
▸ AURKA O14965 1/20 0.43
▸ AURKB Q96GD4 1/20 0.43
▸ CYP1A2 P05177 3/20 0.43
▸ CYP3A4 P08684 1/20 0.43
▸ CYP2D6 P10635 1/20 0.43
▸ CYP2C9 P11712 1/20 0.43
▸ CYP11B1 P15538 1/20 0.43
▸ CYP11B2 P19099 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL13251116 1.00 ACACA (0.51) ACACAGPR84ALOX5KDM4EMAPT
SCHEMBL13251158 0.85 ACACA (0.51) ACACAGPR84KDM4EMAPTALDH1A1
SCHEMBL13251026 0.85 ACACA (0.51) ACACAGPR84KDM4EMAPTALDH1A1
SCHEMBL18088200 0.84 ACACA (0.53) ACACAGPR84ALOX5KDM4EMAPT
SCHEMBL13251065 0.84 ACACA (0.59) ACACAKDM4EMAPTALDH1A1HPGD
SCHEMBL13251023 0.83 ABL1 (0.52) ACACAKDM4EALDH1A1HPGDSMN1; SMN2
SCHEMBL13251173 0.83 CYP1A2 (0.50) ACACAKDM4EALDH1A1SMN1; SMN2ABCB1
SCHEMBL13251104 0.83 ACACA (0.56) ACACAGPR84KDM4EMAPTALDH1A1
SCHEMBL13250990 0.83 ACACA (0.56) ACACAGPR84KDM4EMAPTALDH1A1
SCHEMBL13251040 0.83 CYP1A2 (0.50) ACACAKDM4EALDH1A1SMN1; SMN2ABCB1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8940409-B2 Organic light emitting material and organic light emitting device using the same LG DISPLAY CO., LTD. (KR) 2015-01-27 — — US disclosed
US-8940409-B2 Organic light emitting material and organic light emitting device using the same LG DISPLAY CO., LTD. (KR) 2015-01-27 — — US disclosed
US-20100164374-A1 Organic light emitting material and organic light emitting device using the same LG DISPLAY CO., LTD. (KR) 2010-07-01 — — US disclosed
US-20100164374-A1 Organic light emitting material and organic light emitting device using the same LG DISPLAY CO., LTD. (KR) 2010-07-01 — — US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20100164374-A1 Organic light emitting material and organic light emitting device using the same CRY1, L3MBTL4, TMSB4X ACACA 3658/4885GPR84 1945/4885ALOX5 2939/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.

Send feedback